Skip to main content
Clinical Trials/ACTRN12617000233325
ACTRN12617000233325
Completed
Not Applicable

An observational longitudinal pilot study to assess pharyngeal carriage of Neisseria meningitidis in South Australian university students.

The University of Adelaide0 sites500 target enrollmentFebruary 14, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Invasive Meningococcal disease
Sponsor
The University of Adelaide
Enrollment
500
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 14, 2017
End Date
TBD
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A study to assess the status of patients undergoing surgery of oesophagus (foodpipe) using pedometer (fitness watch) and its relation with complications related to lungs occurring after surgeries and surgical outcomesHealth Condition 1: C15- Malignant neoplasm of esophagusHealth Condition 2: O- Medical and Surgical
CTRI/2024/07/071643Tata Memorial Hospital
Active, not recruiting
Not Applicable
chart review study of patients with chronic liver disease taking Ayurveda treatment to evaluate the effect on Liver functionsHealth Condition 1: K77- Liver disorders in diseases classified elsewhere
CTRI/2017/12/010913Ayurved Clinic
Not yet recruiting
Not Applicable
Pilot prospective observational study to evaluate the safety of Thread Embedding Acupuncture
KCT0007494Sangji University Korean Medical Center100
Not yet recruiting
Not Applicable
ong-term observational study for the assessment of the risk factors for clinical course and functional outcome of the individuals with cerebral aneurysmsI67.1I60.9Cerebral aneurysm, nonrupturedSubarachnoid haemorrhage, unspecified
DRKS00008749eurosurgeon3,000
Active, not recruiting
Phase 1
A 24-week study to evaluate the effect of dapagliflozin (10 mg once daily) plus exenatide (2.0 mg once weekly) on type 2 diabetic patients awaiting for bariatric surgery.Type 2 Diabetes mellitusMedDRA version: 20.0Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2017-001454-33-ESDr. Albert Lecube Torello